Back
Catalyst Pharmaceuticals, Inc. Stock Price Chart
Exxon and Chevron Have an Unlikely New Competitor
DISCLOSURE: EnergyX's Regulation A offering has been qualified by the SEC. Before investing, carefully review the offering circular, including the risk factors. The offering circular is available at
Buy
63
CPRX
Catalyst Pharmaceuticals, Inc.
Last Price:
$22.71
Seasonality Move:
15.27%
7 Day Trial
ALL ACCESS PASS
$
7
The Next Gold Rush
DISCLOSURE: EnergyX's Regulation A offering has been qualified by the SEC. Before investing, carefully review the offering circular, including the risk factors. The offering circular is available at-
The current trend is moderately bearish and CPRX is experiencing selling pressure, which indicates risk of future bearish movement.
Catalyst Pharmaceuticals, Inc. Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 22.81 | Sell |
| 20-day SMA: | 23.36 | Sell |
| 50-day SMA: | 23.04 | Sell |
| 200-day SMA: | 22.17 | Buy |
| 8-day EMA: | 22.9 | Sell |
| 20-day EMA: | 23.1 | Sell |
| 50-day EMA: | 22.65 | Buy |
| 200-day EMA: | 15.29 | Buy |
Catalyst Pharmaceuticals, Inc. Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.11 | Sell |
| Relative Strength Index (14 RSI): | 45.57 | Sell |
| Chaikin Money Flow: | -801716 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (22.74 - 24.06) | Sell |
| Bollinger Bands (100): | (20.25 - 23.21) | Buy |
Catalyst Pharmaceuticals, Inc. Technical Analysis
| Jan 5 | Jan 6 | Jan 7 | Jan 8 | Jan 9 | Jan 12 | Jan 13 | Jan 14 | Jan 15 | Jan 16 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Jan | ||||||||||
| 05 | 06 | 07 | 08 | 09 | 12 | 13 | 14 | 15 | 16 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Catalyst Pharmaceuticals, Inc. Stock
Is Catalyst Pharmaceuticals, Inc. Stock a Buy?
-
Catalyst Pharmaceuticals, Inc. share price is 22.70 while CPRX 8-day simple moving average is 22.81, which is a Sell signal.
-
The stock price of CPRX is 22.70 while Catalyst Pharmaceuticals, Inc. 20-day SMA is 23.36, which makes it a Sell.
-
Catalyst Pharmaceuticals, Inc. 50-day simple moving average is 23.04 while CPRX share price is 22.70, making it a Sell technically.
-
CPRX stock price is 22.70 and Catalyst Pharmaceuticals, Inc. 200-day simple moving average is 22.17, creating a Buy signal.
CPRX Technical Analysis vs Fundamental Analysis
Buy
63
Catalyst Pharmaceuticals, Inc. (CPRX)
is a Buy
Is Catalyst Pharmaceuticals, Inc. a Buy or a Sell?
-
Catalyst Pharmaceuticals, Inc. stock is rated a BuyThe current Catalyst Pharmaceuticals, Inc. [CPRX] share price is $22.70. The Score for CPRX is 63, which is 26% above its historic median score of 50, and infers lower risk than normal.
Catalyst Pharmaceuticals, Inc. Stock Info
Market Cap:
2.8B
Price in USD:
22.70
Share Volume:
892.8K
Catalyst Pharmaceuticals, Inc. 52-Week Range
52-Week High:
26.58
52-Week Low:
19.05
Buy
63
Catalyst Pharmaceuticals, Inc. (CPRX)
is a Buy
Catalyst Pharmaceuticals, Inc. Share Price Forecast
-
What is the Catalyst Pharmaceuticals, Inc. stock price today?The Catalyst Pharmaceuticals, Inc. stock price is 22.70 USD today.
-
Will CPRX stock go up or go down?Catalyst Pharmaceuticals, Inc.> share price is forecast to RISE/FALL based on technical indicators
-
Is Catalyst Pharmaceuticals, Inc. overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Catalyst Pharmaceuticals, Inc. is not overvalued.
Is Catalyst Pharmaceuticals, Inc. Stock a Buy?
-
Catalyst Pharmaceuticals, Inc. share price is 22.70 while CPRX 8-day exponential moving average is 22.90, which is a Sell signal.
-
The stock price of CPRX is 22.70 while Catalyst Pharmaceuticals, Inc. 20-day EMA is 23.10, which makes it a Sell.
-
Catalyst Pharmaceuticals, Inc. 50-day exponential moving average is 22.65 while CPRX share price is 22.70, making it a Buy technically.
-
CPRX stock price is 22.70 and Catalyst Pharmaceuticals, Inc. 200-day simple moving average is 15.29, creating a Buy signal.
Fundamental Analysis of Catalyst Pharmaceuticals, Inc.
Is Catalyst Pharmaceuticals, Inc. a good investment?
-
Analysts estimate an earnings decrease this quarter of $0.13 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.05 per share, and an increase next year of $0.04 per share.
Technical Analysis of Catalyst Pharmaceuticals, Inc.
Should I short Catalyst Pharmaceuticals, Inc. stock?
-
CPRX Moving Average Covergence Divergence (MACD) indicator is -0.11, suggesting Catalyst Pharmaceuticals, Inc. is a Sell
-
Catalyst Pharmaceuticals, Inc. Relative Strength Index (RSI) is 45.57, which suggest Catalyst Pharmaceuticals, Inc. is oversold
-
The Bollinger Bands (25) for Catalyst Pharmaceuticals, Inc. is (22.74 - 24.06), which suggest Catalyst Pharmaceuticals, Inc. is a Buy
-
The Bollinger Bands (100) for Catalyst Pharmaceuticals, Inc. is (20.25 - 23.21), which suggest Catalyst Pharmaceuticals, Inc. is a Buy
* Catalyst Pharmaceuticals, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.